News

American Association of Individual Investors2h
Why ArriVent BioPharma, Inc.’s (AVBP) Stock Is Up 6.01%
ArriVent BioPharma, Inc.’s AVBP share price has surged by 6.01%, which has investors questioning if this is right time to ...
Lipid nanodomains may hold the key to cell signaling mystery
Lipids in cell membranes regulate the activity of a cancer-linked protein, cell biologists at RIKEN have discovered. This ...
HealthDay on MSN9h
Breast Cancer Outcomes Improved With History of Screening Mammography
Prior screening mammography is associated with earlier stage at breast cancer diagnosis and lower breast cancer mortality, ...
American Association of Individual Investors7h
Why CytomX Therapeutics, Inc.’s (CTMX) Stock Is Up 6.39%
CytomX Therapeutics, Inc.’s CTMX share price has surged by 6.39%, which has investors questioning if this is right time to ...
Katie Thurston’s Breast Cancer Treatment Changes: How Does Hormone Therapy Differ From Chemo?
Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer
Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast ...
Deeper understanding of plant cell transformation could pave way for controlling fruit growth
A research team has uncovered the mechanism and underlying reason behind the transformation of residual cells into epidermal ...
Taiwan News8d
Surge in Global Osimertinib Drugs Market – Projected Growth to US$ 11.83 Billion by 2027 Overview of the Global Osimertinib Drugs Market
The global Osimertinib drugs market is on the verge of significant expansion, with an estimated rise in revenue from US$ 4,828.6 million in 2021 to US$ 11,829.8 million by 2027. This growth reflects a ...